Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | acetyl-CoA carboxylase alpha | Starlite/ChEMBL | References |
Homo sapiens | acetyl-CoA carboxylase beta | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | propionyl coenzyme A carboxylase alpha chain | 0.0077 | 0.2385 | 0.2385 |
Plasmodium vivax | biotin carboxylase subunit of acetyl CoA carboxylase, putative | 0.0147 | 0.6601 | 1 |
Toxoplasma gondii | proteasome subunit beta type, putative | 0.0081 | 0.2631 | 0.2631 |
Leishmania major | proteasome beta 5 subunit, putative | 0.0081 | 0.2631 | 0.2631 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0081 | 0.2631 | 0.495 |
Trypanosoma cruzi | 3-methylcrotonyl-CoA carboxylase, putative | 0.0077 | 0.2385 | 0.4488 |
Loa Loa (eye worm) | proteasome A-type and B-type family protein | 0.0081 | 0.2631 | 0.2749 |
Trypanosoma brucei | 3-methylcrotonyl-CoA carboxylase alpha subunit, putative | 0.0077 | 0.2385 | 0.2385 |
Echinococcus granulosus | short transient receptor potential channel 6 | 0.0041 | 0.0174 | 0.0174 |
Leishmania major | acetyl-CoA carboxylase, putative | 0.0203 | 1 | 1 |
Mycobacterium leprae | proteasome (beta subunit) PrcB | 0.0081 | 0.2631 | 1 |
Echinococcus multilocularis | acetyl coenzyme A carboxylase 1 | 0.0203 | 1 | 1 |
Entamoeba histolytica | proteasome subunit beta type 5 precursor, putative | 0.0081 | 0.2631 | 0.5 |
Schistosoma mansoni | methylcrotonyl-CoA carboxylase | 0.0077 | 0.2385 | 0.2385 |
Brugia malayi | olfactory channel protein osm-9 | 0.0041 | 0.0174 | 0.0182 |
Trypanosoma brucei | unspecified product | 0.0051 | 0.078 | 0.078 |
Echinococcus multilocularis | transient receptor potential cation channel | 0.0041 | 0.0174 | 0.0174 |
Brugia malayi | Carboxyl transferase domain containing protein | 0.0196 | 0.9569 | 1 |
Toxoplasma gondii | pyruvate carboxylase | 0.0077 | 0.2385 | 0.2385 |
Schistosoma mansoni | methylcrotonyl-CoA carboxylase | 0.0077 | 0.2385 | 0.2385 |
Schistosoma mansoni | proteasome catalytic subunit 3 (T01 family) | 0.0081 | 0.2631 | 0.2631 |
Leishmania major | carboxylase, putative | 0.0077 | 0.2385 | 0.2385 |
Chlamydia trachomatis | biotin carboxylase | 0.007 | 0.1954 | 0.5 |
Onchocerca volvulus | 0.0038 | 0 | 0.5 | |
Echinococcus multilocularis | proteasome (prosome, macropain) | 0.0081 | 0.2631 | 0.2631 |
Toxoplasma gondii | acetyl-coA carboxylase ACC2 | 0.0203 | 1 | 1 |
Trypanosoma cruzi | 3-methylcrotonyl-CoA carboxylase, putative | 0.0077 | 0.2385 | 0.4488 |
Wolbachia endosymbiont of Brugia malayi | Acetyl/propionyl-CoA carboxylase, alpha subunit | 0.0077 | 0.2385 | 0.5 |
Echinococcus granulosus | proteasome prosome macropain | 0.0081 | 0.2631 | 0.2631 |
Echinococcus multilocularis | transient receptor potential cation channel | 0.0041 | 0.0174 | 0.0174 |
Echinococcus granulosus | transient receptor potential cation channel | 0.0041 | 0.0174 | 0.0174 |
Echinococcus granulosus | propionyl coenzyme A carboxylase alpha chain | 0.0077 | 0.2385 | 0.2385 |
Giardia lamblia | Proteasome subunit beta type 5 precursor | 0.0081 | 0.2631 | 0.5 |
Loa Loa (eye worm) | carboxyl transferase domain-containing protein | 0.0196 | 0.9569 | 1 |
Schistosoma mansoni | acetyl-CoA carboxylase | 0.0203 | 1 | 1 |
Toxoplasma gondii | acetyl-CoA carboxylase ACC1 | 0.0203 | 1 | 1 |
Brugia malayi | Proteasome A-type and B-type family protein | 0.0081 | 0.2631 | 0.2749 |
Onchocerca volvulus | Transient receptor potential cation channel trpm homolog | 0.0038 | 0 | 0.5 |
Schistosoma mansoni | transient receptor potential channel | 0.0041 | 0.0174 | 0.0174 |
Mycobacterium tuberculosis | Proteasome beta subunit PrcB; assembles with alpha subunit PrcA. | 0.0081 | 0.2631 | 1 |
Echinococcus multilocularis | short transient receptor potential channel 6 | 0.0041 | 0.0174 | 0.0174 |
Leishmania major | methylcrotonoyl-coa carboxylase biotinylated subunitprotein-like protein | 0.0077 | 0.2385 | 0.2385 |
Plasmodium falciparum | biotin carboxylase subunit of acetyl CoA carboxylase, putative | 0.0147 | 0.6601 | 1 |
Trypanosoma brucei | proteasome subunit beta type-5, putative | 0.0081 | 0.2631 | 0.2631 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0081 | 0.2631 | 0.495 |
Trypanosoma brucei | 3-methylcrotonyl-CoA carboxylase alpha subunit, putative | 0.0077 | 0.2385 | 0.2385 |
Mycobacterium ulcerans | proteasome PrcB | 0.0081 | 0.2631 | 1 |
Trypanosoma brucei | acetyl-CoA carboxylase | 0.0203 | 1 | 1 |
Trichomonas vaginalis | Family T1, proteasome beta subunit, threonine peptidase | 0.0081 | 0.2631 | 1 |
Onchocerca volvulus | Transient receptor potential cation channel trpm homolog | 0.0038 | 0 | 0.5 |
Trypanosoma cruzi | acetyl-CoA carboxylase | 0.0126 | 0.5315 | 1 |
Schistosoma mansoni | pyruvate carboxylase | 0.0077 | 0.2385 | 0.2385 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0174 | 0.0182 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AUC (ADMET) | = 23.5 ug/hr.ml | AUC in rat at 5 mg/kg, po | ChEMBL. | 17298049 |
CL (ADMET) | = 0.2 L/hr.Kg | Plasma clearance in rat at 5 mg/kg | ChEMBL. | 17298049 |
Cmax (ADMET) | = 2.05 ug ml-1 | Cmax in rat at 5 mg/kg | ChEMBL. | 17298049 |
F (ADMET) | = 98 % | Bioavailability in rat at 5 mg/kg | ChEMBL. | 17298049 |
IC50 (binding) | = 0.63 uM | Inhibition of human recombinant ACC2 expressed in SF9 cells | ChEMBL. | 17298049 |
IC50 (binding) | = 0.63 uM | Inhibition of human recombinant ACC2 expressed in SF9 cells | ChEMBL. | 17298049 |
IC50 (binding) | = 3.35 uM | Inhibition of human recombinant ACC1 expressed in HEK293 cells | ChEMBL. | 17298049 |
IC50 (binding) | = 3.35 uM | Inhibition of human recombinant ACC1 expressed in HEK293 cells | ChEMBL. | 17298049 |
t1/2 (ADMET) | = 4.5 hr | Half life in rat at 5 mg/kg, po | ChEMBL. | 17298049 |
Tmax (ADMET) | = 4.3 hr | Tmax in rat at 5 mg/kg | ChEMBL. | 17298049 |
Vss (ADMET) | = 1.5 L/Kg | Volume of distribution of steady state in rat at 5 mg/kg | ChEMBL. | 17298049 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.